|Articles|March 24, 2022
Structural elucidation for unknown compounds
Author(s)August Bioservices
Accurately identifying analytes that exceed the ICH identification thresholds is critical to a compound’s safety and stability profile in preparation for NDA filing.
Related Content
Sponsored Content
Trending on Pharmaceutical Technology
1
The FDA Moves to Modernize Drug Manufacturing Registration
2
The Implications of Isatuximab-irfc’s FDA Approval for Multiple Myeloma
3
What the Ocrelizumab Deal Does for the Multiple Sclerosis Biosimilar Pipeline
4
PharmTech Weekly Roundup–July 10, 2026
5